Tifcemalimab
Product Specifications
CAS Number
2236068-83-8
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.99
Bioactivity
Tifcemalimab (JS004) is a humanised antibody targeting BTLA (B and T lymphocyte attenuator), which binds to BTLA and blocks the interaction between HVEM and BTLA, exhibiting immunomodulatory and antitumour activity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4558706 1.0 µg DNA
Slc35e2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
orb3004722-01 20 µg
Recombinant Human Probable non-functional immunoglobulin kappa variable 2D-24 (KVD24)
Sign In for Pricing
View Details orb3004722-02 100 µg
Recombinant Human Probable non-functional immunoglobulin kappa variable 2D-24 (KVD24)
Sign In for Pricing
View Details